Article review: The global trend in health losses
Selected results of the Global Burden of Diseases Study 2021
Abstract
The Global Burden of Diseases Study (GBD) was launched in 1991 and has published comprehensive health analyses continuously over the past three decades. Each iteration of the GBD has become more detailed, included more causes, risks and geographic locations, improved the resolution of age-group analyses, and improvements have allowed for additional studies to be conducted. For example, several types of projections have been produced (GBD 2021 Fertility and Forecasting Collaborators, 2024), and estimates of the burden of antimicrobial resistance (Ranjbar & Alam, 2023).
References
Murray, C. J. L., & GBD 2021 Collaborators (2024). Findings from the Global Burden of Disease Study 2021. Lancet (London, England), 403(10440), 2259–2262. https://doi.org/10.1016/S0140-6736(24)00769-4
GBD 2021 Fertility and Forecasting Collaborators (2024). Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet (London, England), 403(10440), 2057–2099. https://doi.org/10.1016/S0140-6736(24)00550-6.
Ranjbar, R., & Alam, M. (2023). Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimi-crobial resistance in 2019: a systematic analysis. Evidence-based nursing, ebnurs-2022-103540. Advance online publication. https://doi.org/10.1136/ebnurs-2022-103540
